2022
DOI: 10.1002/hsr2.926
|View full text |Cite
|
Sign up to set email alerts
|

How to improve information technology strategic planning effectiveness using balanced scorecard, risk and maturity analysis, case study health information technology? A qualitative study

Abstract: Background and Aims Although many health strategic plans have been developed by scholars and organizations, they still suffer from a limited view. Since most health‐related strategies in the future will depend on information technology (IT), as the main driver of today's industry, technology, and society, IT merits attention in health strategic plans. While the majority of the health strategic plan developed based on the interviews and questioner and these plans didn't consider the role of IT in t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
2
0
2

Year Published

2023
2023
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(4 citation statements)
references
References 10 publications
0
2
0
2
Order By: Relevance
“…Strategically planned startups typically have more mature analytics [22]. These results demonstrate a positive path coefficient in startups between analytics maturity and strategic planning [34].…”
Section: Discussionmentioning
confidence: 70%
“…Strategically planned startups typically have more mature analytics [22]. These results demonstrate a positive path coefficient in startups between analytics maturity and strategic planning [34].…”
Section: Discussionmentioning
confidence: 70%
“…Importantly, the serum protein markers are far from satisfactory in the early diagnosis of NSCLC (stage I), displaying AUCs ranging 0.460-0.796 consistent with references [23,75]. Apart from the clinically-adopted serum biomarkers, it was also difficult to differentiate between benign and malignant lesions at an early stage (e.g., SI NSCLC) by other emerging liquid biopsy approaches [72,76], such as integrated analysis of circulating proteins and mutations in cell-free DNA (CancerSeek) showing an accuracy of 43% and sequencing analysis of circulating tumour DNA (Lung-CLiP) showing a sensitivity of 63% [77,78]. Taken together, the surface proteins profiled from exosomes by the assay were capable of identifying malignance, superior to the protein biomarkers recommended by medical association guidelines for liquid biopsy of NSCLC.…”
Section: Assay Of Clinical Sample-derived Exosome For Nsclc Diagnosismentioning
confidence: 94%
“…Adapun perbedaan dengan penelitian yang dilakukan yaitu penelitian terdahulu langsung menentukan domain yang akan digunakan dalam proses audit, dan yang membedakan dengan penelitian ini adalah tidak langsung menentukan domain yang akan digunakan, tetapi terlebih dahulu melakukan tahapan analisa audit, ditahap ini akan dilakukanya pemetaan yang berlaku di COBIT 4.1 yaitu menganalisa audit memiliki beberapa serangkaian tahapan yaitu mengindentifikasi bussines goals, mengindentifikasi IT Goals, mengindentifikasi IT Process, dan mengindentifikasi Control Objective, dengan pemetaan antara Business Goals di PT. Expresssindo System Network sehingga dapat mengidentifikasi domain yang dibutuhkan dalam proses TI Perusahaan [12].…”
Section: Tinjauan Literaturunclassified